CNS vs. CRBG: A Head-to-Head Stock Comparison

Updated on October 3, 2025

Here’s a clear look at CNS and CRBG, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

Symbol	CNS	CRBG
Company Name	Cohen & Steers, Inc.	Corebridge Financial, Inc.
Country	United States	United States
GICS Sector	Financials	Financials
GICS Industry	Capital Markets	Financial Services
Market Capitalization	3.33 billion USD	17.96 billion USD
Exchange	NYSE	NYSE
Listing Date	August 16, 2004	September 16, 2022
Security Type	Common Stock	Common Stock

Historical Performance

This chart compares the performance of CNS and CRBG by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CNS vs. CRBG: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

Symbol	CNS	CRBG
5-Day Price Return	-1.55%	-1.10%
13-Week Price Return	-12.93%	-8.64%
26-Week Price Return	-18.69%	0.06%
52-Week Price Return	-31.44%	10.60%
Month-to-Date Return	-11.17%	0.62%
Year-to-Date Return	-28.95%	7.75%
10-Day Avg. Volume	0.29M	3.68M
3-Month Avg. Volume	0.23M	3.47M
3-Month Volatility	27.81%	23.47%
Beta	1.38	0.95

Profitability

Return on Equity (TTM)

CNS

31.80%

Capital Markets Industry

Max: 38.97%
Q3: 22.24%
Median: 13.52%
Q1: 8.61%
Min: -4.25%

In the upper quartile for the Capital Markets industry, CNS’s Return on Equity of 31.80% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

CRBG

-2.73%

Financial Services Industry

Max: 39.28%
Q3: 18.88%
Median: 9.97%
Q1: 4.03%
Min: -10.25%

CRBG has a negative Return on Equity of -2.73%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.

CNS vs. CRBG: A comparison of their Return on Equity (TTM) against their respective Capital Markets and Financial Services industry benchmarks.

Net Profit Margin (TTM)

CNS

28.55%

Capital Markets Industry

Max: 69.91%
Q3: 37.24%
Median: 24.30%
Q1: 13.06%
Min: -15.18%

CNS’s Net Profit Margin of 28.55% is aligned with the median group of its peers in the Capital Markets industry. This indicates its ability to convert revenue into profit is typical for the sector.

CRBG

-2.30%

Financial Services Industry

Max: 52.16%
Q3: 25.35%
Median: 12.68%
Q1: 6.11%
Min: -11.69%

CRBG has a negative Net Profit Margin of -2.30%, indicating the company is operating at a net loss as its expenses exceeded its revenues.

CNS vs. CRBG: A comparison of their Net Profit Margin (TTM) against their respective Capital Markets and Financial Services industry benchmarks.

Operating Profit Margin (TTM)

CNS

32.18%

Capital Markets Industry

Max: 84.86%
Q3: 47.16%
Median: 32.23%
Q1: 18.65%
Min: -21.87%

CNS’s Operating Profit Margin of 32.18% is around the midpoint for the Capital Markets industry, indicating that its efficiency in managing core business operations is typical for the sector.

CRBG

4.41%

Financial Services Industry

Max: 75.57%
Q3: 37.78%
Median: 19.09%
Q1: 10.04%
Min: -19.42%

CRBG’s Operating Profit Margin of 4.41% is in the lower quartile for the Financial Services industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

CNS vs. CRBG: A comparison of their Operating Profit Margin (TTM) against their respective Capital Markets and Financial Services industry benchmarks.

Profitability at a Glance

Symbol	CNS	CRBG
Return on Equity (TTM)	31.80%	-2.73%
Return on Assets (TTM)	20.74%	-0.09%
Net Profit Margin (TTM)	28.55%	-2.30%
Operating Profit Margin (TTM)	32.18%	4.41%
Gross Profit Margin (TTM)	84.91%	--

Financial Strength

Current Ratio (MRQ)

CNS

0.87

Capital Markets Industry

Max: 3.37
Q3: 1.81
Median: 1.01
Q1: 0.56
Min: 0.04

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

CRBG

Financial Services Industry

Max: 4.83
Q3: 2.70
Median: 1.44
Q1: 0.86
Min: 0.01

For the Financial Services industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

CNS vs. CRBG: A comparison of their Current Ratio (MRQ) against their respective Capital Markets and Financial Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

CNS

0.00

Capital Markets Industry

Max: 6.52
Q3: 2.79
Median: 0.96
Q1: 0.28
Min: 0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

CRBG

0.92

Financial Services Industry

Max: 5.07
Q3: 2.14
Median: 0.66
Q1: 0.12
Min: 0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Financial Services industry.

CNS vs. CRBG: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Capital Markets and Financial Services industry benchmarks.

Interest Coverage Ratio (TTM)

CNS

11.77

Capital Markets Industry

Max: 107.59
Q3: 48.41
Median: 10.85
Q1: 4.56
Min: -36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

CRBG

9.57

Financial Services Industry

Max: 136.23
Q3: 56.08
Median: 6.55
Q1: 2.01
Min: -33.27

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Financial Services industry.

CNS vs. CRBG: A comparison of their Interest Coverage Ratio (TTM) against their respective Capital Markets and Financial Services industry benchmarks.

Financial Strength at a Glance

Symbol	CNS	CRBG
Current Ratio (MRQ)	0.87	--
Quick Ratio (MRQ)	0.87	--
Debt-to-Equity Ratio (MRQ)	0.00	0.92
Interest Coverage Ratio (TTM)	11.77	9.57

Growth

Revenue Growth

CNS vs. CRBG: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

CNS vs. CRBG: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

CNS

3.70%

Capital Markets Industry

Max: 9.02%
Q3: 4.54%
Median: 2.55%
Q1: 1.27%
Min: 0.00%

CNS’s Dividend Yield of 3.70% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

CRBG

3.03%

Financial Services Industry

Max: 8.12%
Q3: 3.37%
Median: 1.70%
Q1: 0.00%
Min: 0.00%

CRBG’s Dividend Yield of 3.03% is consistent with its peers in the Financial Services industry, providing a dividend return that is standard for its sector.

CNS vs. CRBG: A comparison of their Dividend Yield (TTM) against their respective Capital Markets and Financial Services industry benchmarks.

Dividend Payout Ratio (TTM)

CNS

76.12%

Capital Markets Industry

Max: 199.38%
Q3: 99.28%
Median: 60.67%
Q1: 32.00%
Min: 0.00%

CNS’s Dividend Payout Ratio of 76.12% is within the typical range for the Capital Markets industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

CRBG

12.04%

Financial Services Industry

Max: 132.10%
Q3: 64.32%
Median: 18.23%
Q1: 0.00%
Min: 0.00%

CRBG’s Dividend Payout Ratio of 12.04% is within the typical range for the Financial Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

CNS vs. CRBG: A comparison of their Dividend Payout Ratio (TTM) against their respective Capital Markets and Financial Services industry benchmarks.

Dividend at a Glance

Symbol	CNS	CRBG
Dividend Yield (TTM)	3.70%	3.03%
Dividend Payout Ratio (TTM)	76.12%	12.04%

Valuation

Price-to-Earnings Ratio (TTM)

CNS

20.58

Capital Markets Industry

Max: 51.69
Q3: 29.42
Median: 17.58
Q1: 12.55
Min: 5.59

CNS’s P/E Ratio of 20.58 is within the middle range for the Capital Markets industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

CRBG

Financial Services Industry

Max: 45.81
Q3: 30.21
Median: 16.29
Q1: 10.14
Min: 0.70

P/E Ratio data for CRBG is currently unavailable.

CNS vs. CRBG: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Capital Markets and Financial Services industry benchmarks.

Price-to-Sales Ratio (TTM)

CNS

5.87

Capital Markets Industry

Max: 14.65
Q3: 7.29
Median: 4.53
Q1: 2.26
Min: 0.04

CNS’s P/S Ratio of 5.87 aligns with the market consensus for the Capital Markets industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

CRBG

1.18

Financial Services Industry

Max: 10.88
Q3: 5.34
Median: 2.64
Q1: 1.24
Min: 0.06

The P/S Ratio is often not a primary valuation tool in the Financial Services industry.

CNS vs. CRBG: A comparison of their Price-to-Sales Ratio (TTM) against their respective Capital Markets and Financial Services industry benchmarks.

Price-to-Book Ratio (MRQ)

CNS

7.27

Capital Markets Industry

Max: 10.83
Q3: 5.12
Median: 2.66
Q1: 1.19
Min: 0.37

CNS’s P/B Ratio of 7.27 is in the upper tier for the Capital Markets industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

CRBG

1.59

Financial Services Industry

Max: 7.93
Q3: 3.78
Median: 1.49
Q1: 0.88
Min: 0.08

CRBG’s P/B Ratio of 1.59 is within the conventional range for the Financial Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

CNS vs. CRBG: A comparison of their Price-to-Book Ratio (MRQ) against their respective Capital Markets and Financial Services industry benchmarks.

Valuation at a Glance

Symbol	CNS	CRBG
Price-to-Earnings Ratio (TTM)	20.58	--
Price-to-Sales Ratio (TTM)	5.87	1.18
Price-to-Book Ratio (MRQ)	7.27	1.59
Price-to-Free Cash Flow Ratio (TTM)	39.23	8.97